IMRT
Stereotactic radiotherapy for oligometastases: a prognostic model for survival
Aim: to identify subsets of patients that benefit in terms of overall survival 2005 – 2011: 309 patients ≤ 5 mets SBRT (n = 209) or SRS (n = 107) Median delivered BED = 60 Gy (range: 26 – 112 Gy)
Median follow-up = 12 months (range: 1 – 84 months)
De Vin et al, Ann Oncol 2014
11
27-1-2016
Made with FlippingBook